Effect of tumor size on prognosis of nodenegative lung cancer with sufficient lymph node examination and no disease extension

OncoTargets and Therapy

Volumn 9, Issue , 2016, Pages 649-653

  Zhang, Yang ^a,b   Sun, Yihua ^a,b   Chen, Haiquan ^a,b,c  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Non small cell lung cancer; Prognosis; Tumor size

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADOLESCENT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR CLASSIFICATION; TUMOR VOLUME; VERY ELDERLY;

EID: 84957589142     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S98509     Document Type: Article

References (8)

1. Rami-Porta R, Bolejack V, Crowley J, et al; IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions. The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(7):990–1003
2. Zhang J, Gold KA, Lin HY, et al. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry. J Thorac Oncol. 2015;10(4):682–690
3. Rami-Porta R, Ball D, Crowley J, et al; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007;2(7):593–602
4. Maximus S, Nguyen DV, Mu Y, Calhoun RF, Cooke DT. Size of stage IIIA primary lung cancers and survival: a surveillance, epidemiology and end results database analysis. Am Surg. 2012;78(11):1232–1237
5. Morgensztern D, Waqar S, Subramanian J, Gao F, Trinkaus K, Govindan R. Prognostic significance of tumor size in patients with stage III non-smallcell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003. J Thorac Oncol. 2012;7(10):1479–1484
6. Osarogiagbon RU, Ogbata O, Yu X. Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. Ann Thorac Surg. 2014;97(2): 385–393
7. Patz EF Jr, Rossi S, Harpole DH Jr, Herndon JE, Goodman PC. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest. 2000;117(6):1568–1571
8. Black WC. Unexpected observations on tumor size and survival in stage IA non-small cell lung cancer. Chest. 2000;117(6):1532–1534.